We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 28, 2015

One Cycle of BEP Is Feasible for Stage I High-Risk Nonseminomatous Germ-Cell Tumors

Annals of Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Oncology
Long-Term Outcome of Patients With Clinical Stage I High-Risk Nonseminomatous Germ-Cell Tumors 15 Years After One Adjuvant Cycle of Bleomycin, Etoposide and Cisplatin Chemotherapy
Ann. Oncol 2015 Feb 01;26(2)374-377, AD Vidal, GN Thalmann, E Karamitopoulou-Diamantis, MF Fey, UE Studer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading